191 127

Cited 0 times in

Clinical value of pretreatment serum cyfra 21-1 and SCC Ag levels in cervical cancer patients

Other Title
자궁경부암 환자에서 종양표지물질 CYFRA 21-1과 SCC Ag의 치료전 혈청치의 유용성
Authors
오, 기석; 정, 태영; 정, 두용; 유, 희석; 장, 기홍; 전, 미선; 박, 찬희; 박, 영한
Citation
Taehan Sanbuinkwa Hakhoe chapchi, 42(12):2720-2725, 1999
Journal Title
Taehan Sanbuinkwa Hakhoe chapchi; Korean journal of obstetrics and gynecology; 대한산부인과학회잡지
ISSN
0494-4755
Abstract
Objectives: SCC Ag(Squamous cell carcinoma antigen) is so far the most useful tumor marker in assisting clinical diagnosis of cervical cancer and follow-up after therapy. Elevated levels of cytokeratin 19-fragments(CYFRA 21-1) have recently been detected in large proportion of patients with non small cell cancer of the lung, and in particular those with squamous cell carcinoma. This study is to assess the clinical efficacy of CYFRA 21-1 with SCC Ag as the clinicopathologic parameter in cervical cancer. Method: Retrospective analysis of the serum tumor markers CYFRA 21-1 & SCC Ag in eighty cervical cancer patients was performed. Results: Cut off values for SCC Ag & CYFRA 21-1 were 1.94 ng/ml, 3.11 ng/ml respectively. Using the cut-off point, the sensitivity, specificity, positive predictive value(PPV), and negative predictive value(NPV) of serum SCC were 55, 95, 97, 46%, respectively. Serum CYFRA 21-1 showed a sensitivity of 45%, specificity of 91%, PPV of 87%, and NPV of 55%. The combination of SCC and CYFRA 21-1 increased the sensitivity to 62%, with a specificity, PPV, and NPV of 72, 75, 58%. Serum levels of both markers were compared with tumor stage, lesion size and were significantly related. In FIGO stage Ib-IIa, the serum levels of SCC Ag & CYFRA were 2.2±3.9, 2.5±3.6 ng/ml and in FIGO stage IIb-IV, 12.2±15.2, 10.8±11.2 ng/ml. In ≤4cm of lesion size the serum levels of SCC Ag & CYFRA were 3.3±9.0, 4.5±7.6 ng/ml and in >4cm of lesion size, 11.8±11.9, 7.7±9.3 ng/ml. Conclusion: These data seems to show that serum CYFRA 21-1 may be of additional value in assessing the state of disease in some patients with cervical cancer. The prediction of recurrent cervical cancer with SCC Ag were improved by the combination with CYFRA 21-1 but further investigation is needed.
Keywords
SCC AgCYFRA 21-1Cervical cancerTumor marker
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Obstetrics & Gynecology
Files in This Item:
2720-2725.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse